Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Heirman, Carlo" or (type any "bookEditor issueEditor" and editor="Heirman, Carlo")

Add to list
- Journal Article
- A1
- open access
Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice

Patrick Tjok Joe, Ioanna Christopoulou (UGent) , Lien Van Hoecke (UGent) , Bert Schepens (UGent) , Tine Ysenbaert (UGent) , Carlo Heirman, Kris Thielemans, Xavier Saelens (UGent) and Joeri Aerts

(2019) JOURNAL OF TRANSLATIONAL MEDICINE. 17.
Add to list
Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation

Willem Staels (UGent) , Yannick Verdonck, Yves Heremans, Gunter Leuckx, Sofie De Groef, Carlo Heirman, Eelco de Koning, Conny Gysemans, Kris Thielemans, Luc Baeyens, et al.

(2018) DIABETOLOGIA. 61(8). p.1804-1810
Add to list
Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety

Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, Carlo Heirman, Patrick Tjok Joe, Federico Perche, Sarah Maenhout, Sanne Bevers, Katrijn Broos, Kim Deswarte (UGent) , et al.

(2018) ACS NANO. 12(10). p.9815-9829
Add to list
- Journal Article
- A2
- open access
Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon

Katrijn Broos, Kevin Vanderjeught, Janik Puttemans, Cleo Goyvaerts, Carlo Heirman, Heleen Dewitte (UGent) , Rein Verbeke (UGent) , Ine Lentacker (UGent) , Kris Thielemans and Karine Breckpot

(2016) MOLECULAR THERAPY-NUCLEIC ACIDS. 5.
Add to list
- Journal Article
- A1
- open access
The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells

Yannick Willemen, Johan M. J. Van den Bergh, Sarah Bonte (UGent) , Sebastien Anguille, Carlo Heirman, Barbara MH Stein, Herman Goossens, Tessa Kerre (UGent) , Kris Thielemans, Marc Peeters, et al.

(2016) ONCOTARGET. 7(45). p.73960-73970
Add to list
- Journal Article
- A1
Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

Sandra Van Lint (UGent) , Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Dufour, Kevin Van Der Jeught, Lukasz Bialkowski, et al.

(2016) CANCER IMMUNOLOGY RESEARCH. 4(2). p.146-156
Add to list
The ReNAissanCe of mRNA-based cancer therapy

Sandra Van Lint (UGent) , Dries Renmans, Katrijn Broos, Heleen Dewitte (UGent) , Ine Lentacker (UGent) , Carlo Heirman, Karine Breckpot and Kris Thielemans

(2015) EXPERT REVIEW OF VACCINES. 14(2). p.235-251
Add to list
- Journal Article
- A1
- open access
Targeting the tumor microenvironment to enhance antitumor immune responses

Kevin Van Der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, Katrijn Broos, Cleo Goyvaerts, Dries Renmans, Sandra Van Lint (UGent) , Carlo Heirman, Kris Thielemans and Karine Breckpot

(2015) ONCOTARGET. 6(3). p.1359-1381
Add to list
- Journal Article
- A1
- open access
The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy

Heleen Dewitte (UGent) , Sandra Van Lint (UGent) , Carlo Heirman, Kris Thielemans, Stefaan De Smedt (UGent) , Karine Breckpot and Ine Lentacker (UGent)

(2014) JOURNAL OF CONTROLLED RELEASE. 194. p.28-36
Add to list
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula

Sandra Van Lint (UGent) , Sofie Wilgenhof, Carlo Heirman, Jurgen Corthals, Karine Breckpot, Aude Bonehill, Bart Neyns and Kris Thielemans

(2014) CANCER IMMUNOLOGY IMMUNOTHERAPY. 63(9). p.959-967
Add to list
- Journal Article
- A1
- open access
Immunogenicity of targeted lentivectors

Cleo Goyvaerts, Kurt De Groeve, Sandra Van Lint (UGent) , Carlo Heirman, Jo A Vanginderachter, Patrick De Baetselier, Geert Raes, Kris Thielemans and Karine Breckpot

(2014) ONCOTARGET. 5(3). p.704-715
Add to list
In vitro generation of mature, naive antigen-specific CD8⁺ T cells with a single T-cell receptor by agonist selection

SYLVIA SNAUWAERT (UGent) , Greet Verstichel (UGent) , Sarah Bonte (UGent) , Glenn Goetgeluk (UGent) , Stijn Vanhee (UGent) , Yasmine Van Caeneghem (UGent) , Katrien De Mulder (UGent) , Carlo Heirman, Hans Stauss, Miriam HM Heemskerk, et al.

(2014) LEUKEMIA. 28(4). p.830-841
Add to list
- Miscellaneous
mRNA: from a chemical blueprint for protein production to an off-the-shelf therapeutic

Sandra Van Lint (UGent) , Carlo Heirman, Kris Thielemans and Karine Breckpot

(2013) HUMAN VACCINES & IMMUNOTHERAPEUTICS. 9(2). p.265-274
Add to list
- Journal Article
- A1
- open access
Design of an optimized Wilms' tumor 1 (WT1) mRNA construct for enhanced WT1 expression and improved immunogenicity in vitro and in vivo

Daphné Benteyn, Sébastien Anguille, Sandra Van Lint (UGent) , Carlo Heirman, An MT Van Nuffel, Jurgen Corthals, Sebastian Ochsenreither, Wim Waelput, Katrien Van Beneden, Karine Breckpot, et al.

(2013) MOLECULAR THERAPY-NUCLEIC ACIDS. 2.
Add to list
Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy

Perpetua U Emeagi, Sandra Van Lint (UGent) , Cleo Goyvaerts, Sarah Maenhout, Anje Cauwels (UGent) , Lain A McNeish, Tomas Bos, Carlo Heirman, Kris Thielennans, Joeri L Aerts, et al.

(2012) CANCER RESEARCH. 72(6). p.1342-1352

Academic Bibliography

Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice

Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation

Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety

Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon

The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells

Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

The ReNAissanCe of mRNA-based cancer therapy

Targeting the tumor microenvironment to enhance antitumor immune responses

The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy

Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula

Immunogenicity of targeted lentivectors

In vitro generation of mature, naive antigen-specific CD8⁺ T cells with a single T-cell receptor by agonist selection

mRNA: from a chemical blueprint for protein production to an off-the-shelf therapeutic

Design of an optimized Wilms' tumor 1 (WT1) mRNA construct for enhanced WT1 expression and improved immunogenicity in vitro and in vivo

Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy

Contents

Support

Contact